MedPath

Association of lateral location of placenta with development of high blood pressure in pregnancy

Not Applicable
Conditions
Health Condition 1: O149- Unspecified pre-eclampsia
Registration Number
CTRI/2024/01/062111
Lead Sponsor
self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Antenatal women belonging to 18-24 weeks of gestation with singleton pregnancy will be included in the study

Exclusion Criteria

Exclusion criteria

Women with chronic hypertension,

k/c/oDiabetes mellitus,

k/c/o Renal disease,

Severe anaemia,

k/c/oThyrotoxicosis,Gestational diabetes mellitus

Rh negative pregnancy

k/c/oImmunoinflammatory disease

k/c/o vascular disease

Patients with hemorrhagic disorders

k/c/o TORCH infections

Low-lying placenta

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess association of lateral location of placenta with development of pre-eclampsiaTimepoint: At the end of 18 months
Secondary Outcome Measures
NameTimeMethod
TO ASSESS ANY OBSTETRICS COMPLICATION ASSOCIATED WITH DEVELOPMENT OF PRE-ECLAMPSIATimepoint: AT END OF 18 MONTHS
© Copyright 2025. All Rights Reserved by MedPath